Xeloda (capecitabine) for colon cancer

July 2001

You'll see patients taking Xeloda (capecitabine) for colon cancer.

Xeloda was initially approved for breast cancer...now it's the first ORAL treatment approved for metastatic colorectal cancer.

It's an alternative to IV 5-fluorouracil and leucovorin.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Medicare provider status for pharmacists
Thyroid Disorders if the FDA is going to pull Synthroid from the market
Cardiology whether alpha blockers (Cardura, Hytrin, etc) are safe for treating hypertension
Cardiology whether angiotensin receptor blockers should be used to prevent renal problems in type 2 diabetes
Infectious Diseases recent meningitis outbreaks
Infectious Diseases one dose of doxycycline after a tick bite can PREVENT Lyme disease
Oral Health using pilocarpine eyedrops ORALLY to treat severe dry mouth
new triptan for migraines called Axert (almotriptan)
new guidelines that urge earlier intervention for Alzheimer's
Women's Health new oral contraceptive called Yasmin
Allegra-D tablets in their stool
more emphasis on preventing drug-induced liver disease
Hematology & Oncology men who eat moderate amounts of fatty fish have a lower risk of prostate cancer
Hematology & Oncology Xeloda (capecitabine) for colon cancer
Generics speed up approval of generic drugs